Sie nutzen einen Browser, der für diese Website nicht mehr unterstützt wird.
Bitte nutzen Sie die neueste Version von Chrome, Firefox, Edge oder Safari.


Achieving Excellence with Berlin Heart

Sometimes data simply speaks for itself. In this case, the data collected by the ACTION (Advanced Cardiac Therapies Improving Outcomes Network) shows the excellent results of the Berlin Heart EXCOR® system for pediatric patients.  

Note the clinical results based on Niebler et. al (2023) comparing different VADs in patients with a BSA of 0.7 to 1.4 m².   
The data was presented for the ACTION network at the ISHLT 2023. The associated paper can be found here:  https://lnkd.in/dReX83rx
Rob NieblerISHLT - International Society for Heart and Lung Transplantation 
#ourpatientsourmission #vad #pediatric 
The access to some or all shown products may be restricted due to country-specific regulatory approvals. IKUS and EXCOR Active are intended for professional healthcare facility environments only. 
The use of EXCOR® VAD for adults, RVAD-support, EXCOR® Blood pumps with bileaflet valves, EXCOR® Venous Cannula, EXCOR® Arterial Cannula for Graft, Caddy quattro kit as well as Excor mobile is not FDA approved. EXCOR® Active is an investigational device approved for use in a clinical study under IDE# G200252 approved by the FDA.